Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life StudyAndrea Picchianti Diamanti, Annamaria Iagnocco, Giorgio Sesti et al.|Rheumatology and Therapy|2024Cited by 11
Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS studyAndrea Picchianti Diamanti, Annamaria Iagnocco, Valentino Paci et al.|Arthritis Research & Therapy|2025Cited by 1